i10 Productivity
Rankings
AstraZeneca, Sweden ScientistsMedical and Health Sciences / Medical Oncology i10 Productivity Rankings (Sort by last 6 years i10 Index) 2024
Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index". Also see: Universities Rankings 2024 (Sort by : Total i10 Index) and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)
Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
143
129
0.902
Immunotherapy
microbiome
and targeted therapy for oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
79
0.929
molecular pharmacology
oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
83
62
0.747
Immunology-oncology
Microbiome
Mucosal Immunology
T cell immunology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
52
46
0.885
Hematology/Oncology
Immunooncology
Cell Therapy
Drug Development
Biomarkers
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
49
40
0.816
Oncology
Combinations
Drug Resistance
Systems Pharmacology
Trial Design
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
36
31
0.861
oncology
companion diagnostics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
31
28
0.903
Translational medicine
pharmaceutical medicine
oncology
bone metabolism
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
45
24
0.533
oncology
cancer
chemistry
drug discovery
medicinal chemistry
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
29
24
0.828
Oncology
ADC
Drug discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
24
24
1.000
Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
25
20
0.800
oncology
clinical development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
23
20
0.870
Oncology
Genomics
Translational science
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
22
19
0.864
Oncology
Cancer metabolism
apoptosis
targeted therapies
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
19
0.950
Haematology and Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
18
0.545
Cancer
Oncology
Biochemistry
Pharmacology
Drug Discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
25
18
0.720
oncology
drug development
biotechnology
clinical trials
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
27
16
0.593
Oncology
drug discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
22
14
0.636
Clinical research
Lung cancer
Targeted Therapy
Oncology
Methodology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
14
0.824
Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
14
13
0.929
Oncology
Drug Discovery
Drug Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
13
12
0.923
Immunology
Oncology
Cancer Immunotherapy
Drug Delivery
Cancer Vaccine
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
12
12
1.000
Oncology
DNA repair
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
12
12
1.000
oncology
hematology
clinical trials
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
11
0.550
clinical pharmacology
pharmacometrics
Immuno-Oncology
pharmaceutical science
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
12
11
0.917
Maurizio Scaltriti
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
143
129
0.902
Zachary A Cooper
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
79
0.929
Immunotherapy
microbiome
and targeted therapy for oncology
Sylvie Guichard
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
83
62
0.747
molecular pharmacology
oncology
Daniel A Peterson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
52
46
0.885
Immunology-oncology
Microbiome
Mucosal Immunology
T cell immunology
Güllü Topal Görgün
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
49
40
0.816
Hematology/Oncology
Immunooncology
Cell Therapy
Drug Development
Biomarkers
Jay (Jerome) Mettetal
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
36
31
0.861
Oncology
Combinations
Drug Resistance
Systems Pharmacology
Trial Design
Wenjie Xu
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
31
28
0.903
oncology
companion diagnostics
Glen Clack
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
45
24
0.533
Translational medicine
pharmaceutical medicine
oncology
bone metabolism
Frederick W Goldberg
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
29
24
0.828
oncology
cancer
chemistry
drug discovery
medicinal chemistry
Pan Pan
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
24
24
1.000
Oncology
ADC
Drug discovery
Larissa Carnevalli
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
25
20
0.800
Jinyu (Alice) Kang
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
23
20
0.870
oncology
clinical development
Thomas Hedley Carr
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
22
19
0.864
Oncology
Genomics
Translational science
Evangelos Pazarentzos
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
19
0.950
Oncology
Cancer metabolism
apoptosis
targeted therapies
Paul K Stockman
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
18
0.545
Kevin Hudson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
25
18
0.720
Cancer
Oncology
Biochemistry
Pharmacology
Drug Discovery
Tomas Skacel
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
27
16
0.593
oncology
drug development
biotechnology
clinical trials
Yi Yao
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
22
14
0.636
Oncology
drug discovery
Toon Van Der Gronde
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
14
0.824
Clinical research
Lung cancer
Targeted Therapy
Oncology
Methodology
Emma J Davies
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
14
13
0.929
Garrett W. Rhyasen
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
13
12
0.923
Oncology
Drug Discovery
Drug Development
Zahra Gholizadeh, Dvm
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
12
12
1.000
Immunology
Oncology
Cancer Immunotherapy
Drug Delivery
Cancer Vaccine
Anderson T Wang
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
12
12
1.000
Yoshiyasu Aoki
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
11
0.550
oncology
hematology
clinical trials
Xuyang Song
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
12
11
0.917
clinical pharmacology
pharmacometrics
Immuno-Oncology
pharmaceutical science